Darmstadt, Germany and Billerica, MA 2/28/10; Billerica, MA 2/24/10—Merck KGaA has agreed to acquire Millipore for approximately £5.3 million ($7.2 billion), including net debt, or $107 per share in cash. Millipore provides bioproduction and bioresearch products, including life science consumables, filtration and laboratory water products. The deal comes a week after media reports that Thermo […]
Chicago, IL and Santa Clara, CA 2/3/10—Agilent Technologies has sold Hycor Biomedical, which it acquired through its purchase of Stratagene (see IBO 4/15/07), to private equity firm Linden. Terms of the agreement were not disclosed. Hycor develops, manufacturers and markets in vitro diagnostic products for the allergy, autoimmune and urinanalysis markets. “Hycor is an innovative, […]
Waltham, MA 2/1/10; Waltham, MA 2/2/10—Thermo Fisher Scientific has completed its second and third acquisitions this year (see IBO 1/31/10). On February 1, Thermo announced a definitive agreement to purchase Finnzymes, a provider of PCR solutions, including reagents, instruments, consumables and kits, including the Phire and Phusion DNA polymerases. Based in Espoo, Finland, Finnzymes has […]
New York, NY and Tokyo, Japan 2/9/10—Sony Corporation of America has acquired iCyt Mission Technology, a provider of cell sorters, for an undisclosed amount. “We are confident that this acquisition will accelerate the development of Sony’s flow cytometry business by combining Sony’s expertise in the manufacturing of electronics products for consumers and professionals with the […]
Sunnyvale, CA 2/11/10; Washington, DC 2/11/10—Symyx Technologies will transfer the assets of its High Productivity Research (HPR) unit to a new company, HPR Global. The company will receive $8.6 million of positive net working capital from Symyx in return for a $10.0 million note and 19.5% equity stake. Symyx retains rights to royalties and license […]
In the January 31 issue of IBO, the first Executive Briefing on page 2 discussed the divestment of four businesses required by the EU for approval of Agilent’s purchase of Varian. IBO incorrectly identified that Varian’s micro GC business would be sold. It is Agilent’s micro GC business that will be divested.
Foster City, CA and Ontario, Canada 2/1/10; Carlsbad, CA 2/1/10; Ontario, Canada 2/1/10; Washington, DC 2/1/10—Danaher and MDS have announced the completion of Danaher’s acquisition of MDS Analytical Technologies for $650 million in cash (see IBO 9/15/09), which includes the acquisition of MDS Sciex and Life Technologies’ MS joint venture. The new company for the […]
Company Announcements Thermo Fisher Scientific announced in November 2009 that Inverness Medical Innovations ended its supply agreement for Biosite diagnostic products effective July. Annual revenues from the agreement are expected to be $200 million in 2009 and less than half of that in 2010. An agreement with a new supplier is expected to generate $40 […]
Washington, DC 1/28/10—In its fourth-quarter earnings conference call, Danaher announced that Hach Lange has purchased Crison Instruments SA, a manufacturer of electrochemistry instruments and consumables. “Crison’s high-quality, easy-to-use product portfolio strengthens Hach Lange’s e-chem lab and process business,” commented H. Lawrence Culp Jr., CEO and president of Danaher. According to a letter to customers, Crison […]
Toronto, Canada 1/25/10; Toronto, Canada 1/27/10; Washington, DC 1/27/10—The sale of MDS Analytical Technologies to Danaher (see IBO 9/15/09) is expected to close by the end of the first quarter, following the resolution of PerkinElmer’s legal challenge and the approval of the US Federal Trade Commission (FTC). MDS has signed a settlement agreement with PerkinElmer, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
